Cargando…

Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents

The oncological use of cisplatin is hindered by its severe side effects and a very important resistance problem. To overcome these problems, scientists have attempted to design new generation transition-metal anticancer complexes. In this study, we present new complexes, ruthenium(II) [(η(6)-p-cymen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masternak, Joanna, Gilewska, Agnieszka, Barszcz, Barbara, Łakomska, Iwona, Kazimierczuk, Katarzyna, Sitkowski, Jerzy, Wietrzyk, Joanna, Kamecka, Anna, Milczarek, Magdalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475896/ https://www.ncbi.nlm.nih.gov/pubmed/32784666 http://dx.doi.org/10.3390/ma13163491

Ejemplares similares

Similarities and differences in d(6) low-spin ruthenium, rhodium and iridium half-sandwich complexes: synthesis, structure, cytotoxicity and interaction with biological targets
por: Gilewska, Agnieszka, et al.
Publicado: (2019)

Synthesis and Structure of Novel Copper(II) Complexes with N,O- or N,N-Donors as Radical Scavengers and a Functional Model of the Active Sites in Metalloenzymes
por: Masternak, Joanna, et al.
Publicado: (2021)

Structural Insights into New Bi(III) Coordination Polymers with Pyridine-2,3-Dicarboxylic Acid: Photoluminescence Properties and Anti-Helicobacter pylori Activity
por: Kowalik, Mateusz, et al.
Publicado: (2020)

Platinum(II) Complexes with Bulky Disubstitute Triazolopyrimidines as Promising Materials for Anticancer Agents
por: Łakomska, Iwona, et al.
Publicado: (2020)

Vitamin D analogs enhance the anticancer activity of 5-fluorouracil in an in vivo mouse colon cancer model
por: Milczarek, Magdalena, et al.
Publicado: (2013)

Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents
por: Wang, Fang-Xin, et al.
Publicado: (2016)

Development and Application of Ruthenium(II) and Iridium(III) Based Complexes for Anion Sensing
por: Rashid, Ambreen, et al.
Publicado: (2023)

Factors Affecting the Stability of Platinum(II) Complexes with 1,2,4-Triazolo[1,5-a]pyrimidine Derivatives and Tetrahydrothiophene-1-Oxide or Diphenyl Sulfoxide
por: Jakubowski, Mateusz, et al.
Publicado: (2022)

Iridium and Ruthenium Complexes Bearing Perylene Ligands
por: Mauri, Luca, et al.
Publicado: (2022)

Cyclometalated iridium(iii) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents
por: He, Liang, et al.
Publicado: (2015)

Theranostic Lysosomal Targeting Anticancer and Antimetastatic Agents: Half-Sandwich Iridium(III) Rhodamine Complexes
por: Ma, Wenli, et al.
Publicado: (2019)

Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model
por: Maj, Ewa, et al.
Publicado: (2017)

An iridium(iii)-based irreversible protein–protein interaction inhibitor of BRD4 as a potent anticancer agent
por: Zhong, Hai-Jing, et al.
Publicado: (2015)

Synthesis of Platinum(II) Complexes with Some 1-Methylnitropyrazoles and In Vitro Research on Their Cytotoxic Activity
por: Mastalarz, Henryk, et al.
Publicado: (2020)

Studies on the Complexation of Platinum(II) by Some 4-Nitroisoxazoles and Testing the Cytotoxic Activity of the Resulting Complexes
por: Mastalarz, Henryk, et al.
Publicado: (2023)

An Organofluorine Isoselenocyanate Analogue of Sulforaphane Affects Antimetabolite 5-Fluorouracil’s Anticancer Activity: A Perspective for New Combinatory Therapy in Triple-Negative Breast Cancer
por: Milczarek, Małgorzata, et al.
Publicado: (2023)

Highly Cancer Selective Antiproliferative Activity of Natural Prenylated Flavonoids
por: Bartmańska, Agnieszka, et al.
Publicado: (2018)

Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
por: Lee, Sang Yeul, et al.
Publicado: (2020)

Synthesis and in vitro antiproliferative activity of novel (4-chloro- and 4-acyloxy-2-butynyl)thioquinolines
por: Boryczka, Stanisław, et al.
Publicado: (2010)

Assessing the role of membrane lipids in the action of ruthenium(III) anticancer compounds
por: Starosta, Radoslaw, et al.
Publicado: (2023)

Cell Death Mechanism of Organometallic Ruthenium(II) and Iridium(III) Arene Complexes on HepG2 and Vero Cells
por: Kavukcu, Serdar Batıkan, et al.
Publicado: (2023)

New Dinuclear Macrocyclic Copper(II) Complexes as Potentially Fluorescent and Magnetic Materials
por: Barwiolek, Magdalena, et al.
Publicado: (2023)

Efficient Human Breast Cancer Xenograft Regression after a Single Treatment with a Novel Liposomal Formulation of Epirubicin Prepared Using the EDTA Ion Gradient Method
por: Gubernator, Jerzy, et al.
Publicado: (2014)

Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment
por: MILCZAREK, MAGDALENA, et al.
Publicado: (2014)

Carbon‐Supported Bimetallic Ruthenium‐Iridium Catalysts for Selective and Stable Hydrodebromination of Dibromomethane
por: Saadun, Ali J., et al.
Publicado: (2021)

Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents
por: Majcher, Urszula, et al.
Publicado: (2018)

Combined anticancer therapy with imidazoacridinone analogue C‐1305 and paclitaxel in human lung and colon cancer xenografts—Modulation of tumour angiogenesis
por: Świtalska, Marta, et al.
Publicado: (2022)

Lysosomal Targeted Cyclometallic Iridium(Ⅲ) Salicylaldehyde-Coumarin Schiff Base Complexes and Anticancer Application
por: Xu, Ruixi, et al.
Publicado: (2022)

Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity
por: Riccardi, Claudia, et al.
Publicado: (2019)

Interaction between DNA, Albumin and Apo-Transferrin and Iridium(III) Complexes with Phosphines Derived from Fluoroquinolones as a Potent Anticancer Drug
por: Kozieł, Sandra Amanda, et al.
Publicado: (2021)

Synthesis and Biological Activity of Diastereomeric and Geometric Analogs of Calcipotriol, PRI-2202 and PRI-2205, Against Human HL-60 Leukemia and MCF-7 Breast Cancer Cells
por: Milczarek, Magdalena, et al.
Publicado: (2013)

A ruthenium oxide and iridium oxide coated titanium electrode for pH measurement
por: Liu, Baishu, et al.
Publicado: (2020)

Prenylated Flavonoids with Selective Toxicity against Human Cancers
por: Tronina, Tomasz, et al.
Publicado: (2023)

Rational design of iridium–porphyrin conjugates for novel synergistic photodynamic and photothermal therapy anticancer agents
por: Zhang, Liping, et al.
Publicado: (2021)

Synthesis, Characterization and Biological Investigations of Half-Sandwich Ruthenium(II) Complexes Containing Benzimidazole Moiety
por: Rogala, Patrycja, et al.
Publicado: (2022)

Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C(∧)N-Chelated and Pyridine Ligands
por: Liu, Zhe, et al.
Publicado: (2014)

Strategies for conjugating iridium(III) anticancer complexes to targeting peptides via copper-free click chemistry
por: Zhang, Wen-Ying, et al.
Publicado: (2019)

Design, Synthesis, and Anticancer Effect Studies of Iridium(III) Polypyridyl Complexes against SGC-7901 Cells
por: Zhang, Li-Xia, et al.
Publicado: (2019)

The Mode of SN38 Derivatives Interacting with Nicked DNA Mimics Biological Targeting of Topo I Poisons
por: Bocian, Wojciech, et al.
Publicado: (2021)

Synthesis, Anticancer and Antibacterial Activity of Salinomycin N-Benzyl Amides
por: Antoszczak, Michał, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h3vkgrqpo1vuolkn2d7110338q